Related by context. All words. (Click for frequent words.) 75 oral glucose tolerance 71 fasting blood glucose 71 fasting plasma glucose 71 urine albumin 70 hemoglobin A1c HbA1c 70 glycosylated hemoglobin HbA1c 70 HbA1C 69 PSA nadir 69 fructosamine 68 creatinine ratio 68 glycosylated hemoglobin 68 CK MB 68 albumin excretion 68 fasting plasma glucose FPG 68 glucose tolerance test 68 glycated hemoglobin HbA1c 68 HBeAg seroconversion 68 D dimer 68 alanine aminotransferase ALT 68 HOMA IR 68 creatinine levels 68 HbA 1c 68 iPTH 67 test OGTT 67 Hb A1C 67 serum potassium 67 hemoglobin A1C 67 glycated hemoglobin 67 plasma glucose 67 urine cytology 67 glycated hemoglobin levels 67 mL/min/#.# m 2 67 alanine aminotransferase 67 HbA 1c levels 67 periprocedural 67 serum concentrations 67 thyroglobulin 67 #.#mmol L [002] 67 coronary stenosis 67 lispro 67 fasting triglycerides 66 baseline HbA1c 66 calculated creatinine clearance 66 hemoglobin A1c levels 66 serum phosphorous 66 specific antigen PSA 66 biochemical relapse 66 glycemia 66 antibody titer 66 serum urate 66 albumin excretion rate 66 serum cortisol 66 aspartate aminotransferase AST 66 PSADT 66 #.#ng/ml 66 glomerular filtration 66 fasting insulin 65 hemoglobin Hb 65 #ng/ml 65 endometrial thickness 65 cTnI 65 detectable HCV RNA 65 microalbuminuria 65 serum testosterone 65 serum creatinine levels 65 nondiabetic patients 65 -#.# mg dL [002] 65 hemoglobin A1c 65 microalbumin 65 endometrial biopsy 65 aPTT 65 Fasting glucose 65 virological response 65 macroalbuminuria 65 mmol l 65 #mmHg [001] 65 serum aminotransferase levels 65 electrical cardioversion 65 troponin T 65 plasma glucose levels 65 A1c levels 65 MMSE score 65 Fasting blood glucose 65 cTnT 65 pCR 64 liver histology 64 Prostate Specific Antigen 64 HbA1C levels 64 serum urate levels 64 postprocedure 64 IELT 64 urinary albumin 64 recurrent VTE 64 CrCl 64 postintervention 64 â ‰ ¥ 64 estimated GFR 64 serum PSA 64 intact parathyroid hormone 64 glomerular filtration rate 64 HbA1c levels 64 fasting glucose levels 64 serum bilirubin 64 eosinophil count 64 μmol L 64 creatinine clearance 64 virologic failure 64 TURBT 64 intima media thickness 64 aspartate aminotransferase 64 postprandial glucose 64 Hemoglobin A1c 64 postoperative complication 64 Oral Glucose Tolerance 64 HER2 expression 64 serum uric acid 64 Viral load 64 procalcitonin 64 Hypotension 64 triglyceride concentrations 64 colorectal adenoma 64 aminotransferases 63 peak VO2 63 eNO 63 Fasting plasma glucose 63 SGPT 63 lactate dehydrogenase LDH 63 serum CRP 63 platelet reactivity 63 NPH insulin 63 Crohn Disease Activity 63 F FDG PET 63 activated partial thromboplastin 63 -#.# ± [002] 63 QTcF 63 μg liter 63 glycaemia 63 sUA 63 erythrocyte sedimentation rate 63 Ejection Fraction 63 Index CDAI 63 fasting plasma 63 nondiabetics 63 mmHg diastolic 63 virologic response 63 advanced adenoma 63 nonfasting 63 hypoglycemic episodes 63 % Confidence Interval 63 hsCRP levels 63 isoprostane 63 lowest tertile 63 lumbar spine BMD 63 thyroid stimulating hormone 63 biochemical recurrence 63 spirometric 63 HBV DNA levels 63 hematological parameters 63 β blockers 63 nonobstructive CAD 63 MADRS score 63 serum phosphate 63 elevated fasting glucose 63 HbA1c 63 serum magnesium 63 mmol L 63 atorvastatin #mg 63 transaminases 63 Multivariate analysis 62 #mmHg [002] 62 baseline serum creatinine 62 serum phosphorus 62 transferrin saturation 62 CIN3 62 serum TSH 62 fasting glucose 62 umol L 62 pg mL 62 insulin detemir 62 asymptomatic carotid stenosis 62 polyp recurrence 62 serum glucose 62 QTc prolongation 62 primary aldosteronism 62 CC genotype 62 LANTUS R 62 Non inferiority 62 cardiac troponin T 62 postdose 62 hs CRP 62 glucose concentrations 62 sustained virologic response 62 paricalcitol 62 detemir 62 AST ALT 62 #mg/dL [001] 62 tPSA 62 APTIVUS r 62 hemodilution 62 serum lipid 62 neutrophil counts 62 paraprotein 62 CIN2 + 62 REYATAZ r arm 62 lymphocyte count 62 QIDS SR 62 estimated glomerular filtration 62 undetectable HBV DNA 62 clinically meaningful reductions 62 serum triglycerides 62 methacholine challenge 62 immunostaining 62 mm Hg diastolic 62 serum prostate 62 carotid intima media 62 serum HCV RNA 62 pretest probability 62 blood glucose concentrations 62 creatine kinase 62 mmol L. 62 homocysteine concentrations 62 μg kg 62 nonfasting triglyceride levels 62 euthyroid 62 urinary N telopeptide 62 mL kg 62 d dimer 62 elevated LDL cholesterol 62 mcg mL 62 transaminase elevations 62 serum calcium 62 elevated ALT 62 ml kg 62 elevated creatinine 62 oral antidiabetic medication 62 atherogenic dyslipidemia 62 Serum creatinine 62 extrapyramidal symptoms 62 ng dL 62 corrected QT interval 62 μg dL 62 pharmacokinetic PK profile 62 posttreatment 62 urine NGAL 62 plasma folate 62 log# reduction 62 Pharmacokinetic parameters 62 + PH# 62 Hgb 62 FDG uptake 62 intensive statin therapy 62 serum phosphate levels 61 impaired fasting glucose 61 Prostate specific antigen 61 serum sodium 61 urine dipstick 61 alanine transaminase 61 log# copies mL 61 plasma triglycerides 61 serum homocysteine 61 nmol liter 61 metabolite concentrations 61 univariate analysis 61 pelvic ultrasound 61 glycated albumin 61 mm Hg systolic 61 #mg/dl 61 NIHSS score 61 urinary albumin excretion 61 artery stenosis 61 squamous intraepithelial lesions 61 serum ferritin 61 moderate renal impairment 61 advanced adenomas 61 pT3 61 SGOT 61 definite stent thrombosis 61 HBeAg 61 pulmonary artery pressure 61 ertapenem 61 insulin degludec 61 D Dimer 61 tirofiban 61 creatinine 61 SLNB 61 SpO 2 61 plasma cortisol 61 6MWD 61 optical colonoscopy 61 Response Evaluation Criteria 61 serum IGF 61 #mg/day [001] 61 leukocyte count 61 Montgomery Åsberg Depression 61 fasting serum 61 EDSS score 61 posttransplant 61 BENICAR HCT 61 ADAS Cog 61 Cystatin C 61 #mg/day [002] 61 tipranavir r 61 nicardipine 61 ALT elevations 61 overt hypothyroidism 61 severe exacerbations 61 urinary sodium excretion 61 Primary endpoints 61 upper endoscopy 61 STRIDE PD 61 ABC/3TC 61 pg ml 61 carotid IMT 61 mg dL 61 Cmax 61 #mg dose [002] 61 premenopause 61 EBRT 61 renal artery stenosis 61 undetectable PSA 61 ALT normalization 61 advanced neoplasia 61 thyrotropin 61 mEq L 61 aminotransferase levels 61 hematologic toxicity 61 triacylglycerol concentrations 61 apnea hypopnea index 61 postoperative mortality 61 pulmonary arterial 61 protein excretion 61 hypoglycemic events 61 tertiles 61 NNT = 61 prothrombin 61 methacholine 61 x ULN 61 CCyR 61 #Gy 61 oral antidiabetes 61 pmol L 61 ASCUS 61 overt nephropathy 61 pulmonary angiography 61 multivariate Cox 61 transthoracic 61 N telopeptide 61 LDL HDL 61 statistical significance p 61 postprandial blood glucose 61 Liver biopsy 61 complete cytogenetic response 61 DAS# [002] 61 silent myocardial ischemia 61 albuminuria 61 hemorrhagic complications 61 ANOVA 61 Subgroup analysis 61 PaO 2 61 #/#mmHg 61 mean baseline HbA1c 61 fasting triglyceride levels 60 triiodothyronine 60 salivary cortisol 60 cecal intubation 60 nmol 60 HCV antibody 60 sensitivity specificity 60 bronchial hyperresponsiveness 60 Hb A1c 60 serum sodium levels 60 intravesical therapy 60 symptomatic VTE 60 highest tertile 60 URTI 60 LV dysfunction 60 hemoglobin hematocrit 60 timepoints 60 DEXA scans 60 abacavir lamivudine 60 logistic regression analysis 60 nmol L 60 dose atorvastatin 60 hemoglobin concentrations 60 HGPIN 60 severe neutropenia 60 clopidogrel pretreatment 60 adrenalectomy 60 lymphocytosis 60 total cholesterol LDL 60 preoperative PSA 60 prolonged QT interval 60 fructose intolerance 60 hypokalemia 60 hypophosphatemia 60 beta blocker therapy 60 liver biopsies 60 mg dl 60 adjunctive placebo 60 chest radiographs 60 interrater reliability 60 serum testosterone levels 60 abdominal adiposity 60 hyperalgesia 60 GH deficiency 60 univariate analyzes 60 esophagogastroduodenoscopy 60 carotid stenosis 60 SCr 60 #.#mg/dL 60 preoperatively 60 MetS 60 NIHSS 60 Montgomery Asberg Depression 60 conditional logistic regression 60 grade cervical intraepithelial 60 clomipramine 60 confidence intervals CIs 60 BENICAR 60 CI -#.# 60 CI #.#-#.# [001] 60 elevated triglyceride levels 60 FDG-PET/CT 60 baseline LDH 60 hypercalciuria 60 adenomatous polyps 60 Visual Analogue Scale VAS 60 transaminase levels 60 antigen PSA levels 60 International Normalized Ratio 60 multivariate analyzes 60 abnormal cytology 60 budesonide pMDI 60 mmol liter 60 Kaplan Meier analysis 60 postprandial insulin 60 NSTE ACS 60 reinfarction 60 apolipoprotein B 60 glycosylated hemoglobin levels 60 β blocker 60 pyrazinamide 60 p = .# [002] 60 troponins 60 ìg 60 -#.# log# 60 mIU ml 60 DAS# CRP 60 serum triglyceride 60 pulmonary capillary wedge 60 per deciliter mg 60 serum ALT 60 hyperglycaemia 60 TT genotype 60 QTc 60 hemoglobin concentration 60 Brief Psychiatric 60 Orthostatic hypotension 60 1c HbA 1c 60 IgG antibody 60 IU ml 60 serum HBV DNA 60 serum insulin 60 glulisine 60 hydroxy vitamin D 60 albumin creatinine ratio 60 undetectable HCV RNA 60 blood Phe levels 60 mCi 60 myocardial necrosis 60 binary restenosis 60 multivariable analysis 60 PASI scores 60 sodium excretion 60 eplerenone 60 VCUG 60 transurethral resection 60 glucose insulin 60 Alkaline Phosphatase 60 total cholesterol triglycerides 60 flow mediated dilation 60 skin prick 60 CDAI score 60 microg 60 metabolic parameters 60 abdominal ultrasound 60 CIN3 + 60 thyroxine 60 TRUS 60 ALT elevation 60 nocturnal hypoglycaemia 60 plasma leptin 60 QT intervals 60 diameter stenosis 60 hypogonadal 60 cTnT levels 60 urinary calcium 60 serum calcium levels 60 pentoxifylline 60 adenoma recurrence 60 CLA supplementation 60 morphometric vertebral fractures 60 hemodynamic parameters 60 anemia hemoglobin 60 Glomerular filtration rate 60 epithelial ovarian cancer 60 subclinical hypothyroidism 59 #.#/#.# mmHg [001] 59 NT proBNP 59 subscore 59 genotypic resistance 59 pulmonary exacerbation 59 UGT#A# * 59 thickness CIMT 59 conventional angiography 59 adenotonsillectomy 59 perioperative complications 59 mU L 59 adenoma detection 59 triglyceride concentration 59 undetectable viral 59 dehydroepiandrosterone sulfate 59 sUA levels 59 #mg/dL [002] 59 mg kg dose 59 Univariate analysis 59 sitosterol 59 Hypoglycaemia 59 bolus dose 59 prostate cancer CaP 59 Myelosuppression 59 ALT flares 59 hematopoietic cancers 59 lopinavir r arm 59 elevated serum creatinine 59 pelvic lymphadenectomy 59 bronchoalveolar lavage 59 atazanavir ritonavir 59 systolic BP 59 malignant nodules 59 postprandial glycemia 59 Hb levels 59 intravenous diuretics 59 cervical intraepithelial neoplasia 59 invasive coronary angiography 59 mIU L 59 eGFR 59 polyp detection 59 IPSS 59 coronary arteriography 59 nonfatal MI 59 serum estradiol 59 rFSH 59 normotensive 59 digital rectal examination 59 CVD mortality 59 ritonavir boosted 59 Insulin sensitivity 59 fluvastatin 59 Tmax 59 isoenzyme 59 intravaginal ejaculatory latency 59 QRS duration 59 lactulose 59 QTc intervals 59 uM 59 salivary flow 59 colonoscopic 59 BRCA2 mutation carriers 59 μg d 59 Hematocrit 59 total thyroidectomy 59 pT2 59 benazepril 59 endometrial hyperplasia 59 C Reactive Protein 59 clinically meaningful improvement 59 posttest 59 platelet inhibition 59 tHcy 59 preintervention 59 haematologic 59 p = NS 59 CR nPR 59 LDL triglycerides 59 diastolic hypertension 59 ^ sup #m 59 TURP 59 obstructive CAD 59 multivariate adjustment 59 ACR# response 59 SVR# 59 PRADAXA #mg 59 hours postdose 59 fibrinolysis 59 intravascular ultrasonography 59 % CI #.#-#.# [003] 59 perioperative morbidity 59 T2DM 59 #OHD levels 59 baseline FEV 59 HBsAg 59 Ramipril 59 aminotransferase 59 tertile 59 Kruskal Wallis test 59 mmHg systolic 59 vasopressor 59 perioperatively 59 chemoradiation therapy 59 corticosteroid dose 59 Prostate Specific Antigen PSA 59 interferon ribavirin 59 chi squared 59 #mm Hg 59 urodynamic 59 thyroid stimulating hormone TSH 59 response CCyR 59 Postoperative 59 postoperative morbidity 59 rheumatoid factor 59 revascularizations 59 left ventricular dysfunction 59 Radical prostatectomy 59 serum creatinine 59 Subgroup analyzes 59 liver biopsy 59 Postoperative complications 59 NGAL 59 serum IgE 59 MMSE scores 59 urinary excretion 59 elevated LDH 59 radioiodine therapy 59 Heavy menstrual bleeding 59 cystatin C 59 Bonferroni correction 59 Secondary efficacy endpoints 59 needle aspiration 59 HER2 overexpression 59 lupus anticoagulant 59 Hazard Ratio HR 59 nonfatal myocardial infarction 59 relapsed MM 59 serum markers 59 mild renal insufficiency 59 Retreatment 59 vaginal hysterectomy 59 MMSE 59 mU liter 59 univariate 59 intraobserver 59 exhaled nitric oxide 59 diuretic chlorthalidone 59 coronary angiography 59 Creatinine 59 secondary efficacy endpoint 59 aminotransferase ALT 59 induced sputum 59 cefotaxime 59 NNRTI resistance 59 DAS# remission 59 postop 59 Apgar scores 59 deoxy 59 transaminase 59 serum thyroglobulin 59 guaiac 59 unpaired t 59 radiotherapy RT 59 PegIFN RBV 59 complete cytogenetic 59 myocardial reperfusion 59 g dl 59 NYHA functional class 59 deoxyglucose 59 pneumonectomy 59 Cystectomy 59 Plasma concentrations 59 serum retinol 59 exhaled NO 59 permanently discontinue Vectibix 59 dalteparin 59 carotid artery intima media 59 multivariate logistic regression 59 apnea hypopnea 59 manometry 59 FEV1 59 abnormal Pap 59 P = .# 59 serum lipid levels 59 ribavirin therapy 59 SUVmax 59 ug kg 59 BMI z 59 Triglyceride levels 59 insulin secretagogue 59 angiotensin II receptor blockers 59 plasma HCV RNA 59 serum potassium levels 59 lispro alone 59 ADAS cog 59 acromegalic patients 58 -#.# log# copies mL 58 apolipoprotein A1 58 A1C levels 58 mg/m2 dose 58 Severe hypoglycemia 58 follicular phase 58 cytoreductive surgery 58 elevated transaminases 58 mg BID dose 58 homozygotes 58 quantitative coronary angiography 58 aminotransferase elevations greater 58 neutropaenia 58 variance ANOVA 58 XIENCE V PROMUS Stent 58 postprandial hyperglycemia 58 irbesartan 58 PREZISTA r arm 58 transcranial Doppler ultrasound 58 lactate dehydrogenase 58 NHANES III 58 χ 58 serum albumin 58 edifoligide 58 -#.# mg dL [001] 58 hydroxyvitamin D levels 58 fosamprenavir 58 nonobese 58 Haptoglobin 58 Rating Scale MADRS 58 systolic hypertension 58 systemic hypotension 58 pre eclamptic 58 hypertensives 58 ventricular tachyarrhythmia 58 arterial thromboembolic events 58 HDL Cholesterol 58 Partial Response 58 Ishak fibrosis score 58 systolic diastolic 58 sonographically guided 58 oral anticoagulation 58 curative resection 58 NIH CPSI 58 pretreatment serum 58 renal cysts 58 IDDM 58 rebleeding 58 Hemoglobin A1C 58 EDSS scores 58 HIV RNA 58 prospectively defined 58 neurodevelopmental outcome 58 HIV uninfected 58 serum PTH 58 rosuvastatin #mg 58 sulphonylureas 58 Apidra ® 58 adjunctive ABILIFY 58 cystoscopic 58 Intraocular pressure 58 intravitreal injections 58 endometrial carcinoma 58 concomitant medications 58 Solid Tumors criteria 58 rizatriptan 58 hsCRP 58 abdominal computed tomography 58 transvaginal sonography 58 duplex ultrasonography 58 pharmacokinetic characteristics 58 thromboembolic 58 salmeterol fluticasone 58 thyrotropin levels 58 PCa 58 detrusor 58 TMP SMX 58 underwent surgical resection 58 NMIBC 58 IgA deficiency 58 elevated blood glucose 58 severe renal impairment 58 bioavailable testosterone 58 Febrile neutropenia 58 transient elastography 58 residual platelet reactivity 58 WOMAC pain 58 maximal aerobic capacity 58 LEXIVA r 58 Adjuvant chemotherapy 58 lymphocyte counts 58 HAQ DI 58 abdominal circumference 58 extracapsular extension 58 Cardiac Troponin 58 flutamide 58 CR CRu 58 extubation 58 aldosterone antagonist 58 baseline FEV1 58 multiple logistic regression 58 dapagliflozin plus 58 State Examination MMSE 58 APOE e4 58 UACR 58 serum triglyceride levels 58 ARB telmisartan 58 NOAEL 58 TEAEs 58 inotropic 58 HER2 amplification 58 parasitaemia 58 follicle stimulating hormone FSH 58 cerebrovascular events 58 RECIST Response Evaluation Criteria 58 hyperphenylalaninemia HPA due 58 HbA 1C 58 efficacy endpoint 58 semiquantitative 58 sustained virological response 58 Wilcoxon rank sum 58 cytologic 58 AUC0 58 orchiectomy 58 desvenlafaxine succinate 58 μg ml 58 cortisol concentrations 58 ejection fractions 58 Stent thrombosis 58 SSRI citalopram 58 % CI #.#-#.# [004] 58 VKORC1 58 PCWP 58 ribavirin RBV 58 Alanine 58 proximal DVT 58 severe hypoglycemia 58 achieved ACR# 58 induction regimen 58 MACCE 58 catheter angiography 58 stratifying patients 58 inhibin B 58 adenoma 58 doxorubicin cyclophosphamide 58 comparator arm 58 reticulocytes 58 anti JCV antibodies 58 subcutaneous enoxaparin 58 prolactin levels 58 Hb 58 gross hematuria 58 timepoint 58 p = #.# [003] 58 retest reliability 58 proBNP 58 Tasigna prolongs 58 low expressors 58 crossclamp 58 serum phosphorus levels 58 #mg dose [003] 58 cilostazol 58 heterozygotes 58 ULORIC 58 ipsilateral stroke 58 salmeterol fluticasone propionate 58 IOP lowering 58 lipid parameters 58 elevated uric acid 58 LDL cholesterol concentrations 58 MBq 58 angiographically 58 postinjury 58 Alzheimer Disease Assessment 58 Y BOCS 58 gliclazide 58 urinary cortisol 58 pulmonary dysfunction 58 DEXA scan 58 osteopenic 58 cerebral angiography 58 doxorubicin docetaxel 58 lamivudine refractory patients 58 oral prednisone 58 maximal dose 58 eptifibatide 58 neutrophil count 58 surgical biopsy 58 ± SEM 58 ACR# responses 58 HBeAg negative 58 diabetes mellitus DM 58 Visual acuity 58 interquartile range 58 extracolonic findings 58 overnight polysomnography 58 adiponectin concentrations 58 virological failure 58 nephrectomy 58 pathologic examination 58 OADs 58 abdominal hysterectomy 58 ADCS CGIC 58 metformin sulphonylurea 58 proteinuria 58 serum lactate 58 poor metabolizers 58 leiomyomas 58 progression TTP 58 ‰ ¥ 58 Low density lipoprotein 58 gestational diabetes mellitus 58 depressive symptomatology 58 gastric pH 58 cytopenias 58 hepatic function 58 mL/min/#.# m2 58 thickness IMT 58 interobserver reliability 58 hMG 58 hepatectomy 58 Insulin PH# 58 remission CR 58 Coronary Artery Bypass Graft 58 cardiac troponin 57 Inhibin B 57 arterial oxygen saturation 57 K ras mutations 57 AGHD 57 endoscopic remission 57 hematologic parameters 57 % CI #.#-#.# [007] 57 ischemic lesions 57 oxyhemoglobin 57 trough FEV1 57 EDARBI 57 hepatic enzymes 57 tuberculin skin testing 57 dose clopidogrel 57 lipid lowering therapy 57 ACTH 57 ml min 57 bacteriuria 57 NT proBNP concentrations 57 histopathologic findings 57 evaluable subjects 57 Negative Syndrome 57 echocardiographic parameters 57 FOLPI 57 airway responsiveness 57 multivariable adjusted 57 hyperoxaluria 57 Index CDAI score 57 Main Outcome Measure 57 Qmax 57 SHBG levels 57 severe hypoglycaemia 57 malignant lesions 57 serum BDNF 57 Cardiorespiratory fitness 57 Mg Uk 57 EXJADE 57 nmol L. 57 experienced virologic failure 57 intracerebral haemorrhage 57 tranylcypromine 57 #.#/#.# mm Hg [003] 57 regression coefficient 57 NAbs 57 Left Ventricular Ejection Fraction 57 coronary revascularization 57 anti HBs 57 transrectal ultrasound guided 57 #OHD 57 carotid endarterectomy CEA 57 nausea photophobia 57 pharmacokinetic parameters 57 antihypertensive medications 57 Cholinesterase Inhibitors 57 ULN 57 plasma renin 57 mediated dilation 57 LVSD 57 lipoprotein levels 57 antihypertensive therapy 57 #ß 57 atrioventricular block 57 mercaptopurine 57 dose titration 57 cholesterol LDL C 57 NovoLog ® Mix 57 atheroma volume 57 luteal phase 57 oxycodone CR 57 normothermic 57 unfractionated heparin